The Comparison of Changes in Behavior, Neurochemistry, Endocrine, and Immune Functions after Different Routes, Doses and Durations of Administrations of IL-1β in Rats

Background: Increased interleukin-1β (IL-1) in the brain and periphery has been associated with neurodegenerative and psychiatric disorders. However, results from different IL-1 sources, administrating routes, doses and treatment duration were inconsistent and confused. The neuroendocrine-immune mechanism by which IL-1-induced behavioral changes occur is still unclear. Methods: In the present study, the acute and sub-chronic effects of rat recombinant IL-1, following either intraperitoneal (ip) or intracerebroventricular (icv) injection, were studied on the behavior, corticosterone secretion, peripheral inflammatory responses and brain monoamines. Results: In the open field apparatus, IL-1 (ip) increased locomotor activity but decreased the activity following icv administration. IL-1 had a greater anxiogenic effect in the elevated plus maze after icv than after ip administration. In the Morris water maze spatial memory was only impaired following sub-chronic and icv administration. Both acute and sub-chronic IL-1 increased the serum corticosterone concentration and decreased the release of the anti-inflammatory cytokine IL-10 from whole blood cultures. However, centrally administered IL-1 increased, while peripherally administered decreased, the release of PGE2 from blood cultures. After sub-chronic administration, the noradrenaline concentration was decreased in several limbic regions, while the turnovers of serotonin and dopamine were increased. Discussion: These results suggest that 1) IL-1 effects depended on the dose, route and duration of administration, and 2) IL-1 enhances the responsiveness of rats to stressful environmental stimuli. In addition, the sub-chronic administration of IL-1 induces behavioral, neurotransmitter, hormonal and immune changes that may be causally implicated in the mechanism of some of psychiatric disorders such as depression.

References

• 1 Anisman H, Merali Z. Anhedonic and anxiogenic effects of cytokine exposure.  Adv Exp Med Biol. 1999;  461 199-233
• 2 Bai X F, Zhu J, Zhang G X, Kaponides G, Hojeberg B, van der Meide P H. IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses.  Clin Immunol Immunopathol. 1997;  83 117-126
• 3 Bellinger F P, Madamba S G, Siggins G R. IL-1 beta inhibits synaptic strength and long term potentiation in the rat.  Brain Res. 1993;  628 227-234
• 4 Bluthe R M, Dantzer R, Kelley K W. Central mediation of the effects of IL-1 on social exploration and body weight in mice.  Psychoneuroendocrinol. 1997;  22 1-11
• 5 Breder C D, Dinarello C A, Saper C B. Interleukin-1 immunoreactive innervation of the human hypothalamus.  Science. 1988;  240 321-324
• 6 Castanon N, Bluthe R M, Dantzer R. Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behaviour induced by peripheral but not central lipopolysaccharide and IL-1 beta in the rat.  Psychopharmacol. 2001;  154 50-60
• 7 Connor T J, Song C, Leonard B E, Merali Z, Anisman H. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat.  Neuroscience. 1998;  84 923-933
• 8 Cresani F, Seguy F, Dantzer R. Behavioral effects of peripherally injected IL-1: role of prostaglandins.  Brain Res. 1991;  542 330-335
• 9 Dantzer R, Bluthe R M, Aubert A, Goodall G, Bred-Dibat J -L, Kent S. Cytokine actions on behaviour. In Rothwell NJ. (ed) Cytokines and the nervous system. London; Landes 1996: 117-144
• 10 Dantzer R, Bluthe R M, Kelley K W. Androgen-dependent vasopressinergic neurotransmission attenuates interleukin-1-induced sickness behavior.  Brain Res. 1991;  557 115-120
• 11 de Groote L, Penalva R G, Flachskamm C, Reul J M, Linthorst A C. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.  J Neurochem. 2005;  94 45-56
• 12 De la Fuente M, Hernanz A, Medina S, Guayerbas N, Fernandez B, Viveros M P. Characterization of monoaminergic systems in brain regions of prematurely ageing mice.  Neurochem Int.. 2003;  43 165-172
• 13 Diamant M, de Wied D. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats.  Endocrinology. 1991;  129 446-454
• 14 Dinarello C A. Biology of interleukin-1.  FASEB J. 1988;  2 108-115
• 15 Dunn A J. Systemic IL-1 administration stimulates hypothalamic noradrenaline metabolism paralleling the increased plasma corticosterone.  Life Sci. 1988;  43 429-435
• 16 Dunn A J, Antoon M, Chapman Y. Reduction in exploratory behaviour by intraperitoneal injection of IL-1 involves brain CRF.  Brain Res Bull. 1991;  26 539-542
• 17 Dunn A J, Swiergiel A H. Behavioral responses to stress are intact in CRF-deficient mice.  Brain Res. 1999;  845 4-20
• 18 Egawa T, Mishima K, Egashira N, Fukuzawa M, Abe K, Yae T, Iwasaki K, Fujiwara M. Impairment of spatial memory in kaolin-induced hydrocephalic rats is associated with changes in the hippocampal cholinergic and noradrenergic contents.  Behav Brain Res. 2002;  129 31-39
• 19 Farrar W L, Kilian P L, Ruff M R, Hill J M, Pert C B. Visualization and characterization of interleukin 1 receptors in brain.  J Immunol. 1987;  139 459-463
• 20 Gibertini M, Newton C, Friedman H, Klein T W. Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta.  Brain Behav Immun. 1995;  9 113-128
• 21 Gray J A, Lalljee B. Sex differences in emotional behaviour in the rat: correlation between open-field defecation and active avoidance.  Anim Behav. 1974;  22 856-861
• 22 Harro J, Tonissaar M, Eller M, Kask A, Oreland L. Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistry.  Brain Res. 2001;  899 227-239
• 23 Hart B L. Biological basis of the behavior of sick animals.  Neurosci Biobehav Rev. 1988;  12 123-137
• 24 Kabierisch A, Del Rey A, Honegger C G, Besedovsky H O. Interleukin-1 induces changes in norepinephrine in the rat brain.  Brain Behav Immun. 1988;  2 267-274
• 25 Katsuki H, Nakai S, Hirai Y, Akaji K I, Kiso Y, Satoh M. Interleukin-1 inhibits long term potentiation in the CA3 region of the mouse hippocampal slice.  Eur J Pharmacol. 1990;  181 323-326
• 26 Kent S, Bluthe R M, Kelleyn K W, Dantzer R. Sickness behaviour as a target for drug development.  Trends Pharmacol Sci. 1992;  13 24-28
• 27 Ledeboer A, Binnekade R, Breve J J, Bol J G, Tilders F J, Van Dam A M. Site-specific modulation of LPS-induced fever and interleukin-1 beta expression in rats by interleukin-10.  Am J Physiol Regul Integr Comp Physiol. 2002;  282 R1762-1772
• 28 Maes M. A review on the acute phase response in major depression.  Rev Neurosci. 1993;  44 466-469
• 29 Maes M. Evidence for an immune response in major depression: a review and hypothesis.  Prog Neuropsychopharmacol Biol Psychiatry. 1995;  19 11-38
• 30 Maier S F, Watkins L R. Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock.  Brain Res. 1995;  695 278-282
• 31 March C J, Mosley B, Larsen A, Cerreti D P, Braedt G, Price V. Cloning, sequence and expression of two distinct human interleukin-1 complimentary DNA’s.  Nature. 1985;  315 641-647
• 32 Moldofsky H. Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome.  Adv Neuroimmunol. 1995;  5 39-56
• 33 Morris R GM. Modeling amnesia and the study of memory in animals.  Trends Neurosci. 1983;  6 479-483
• 34 Neumann H. Control of glial immune function by neurons.  Glia. 2001;  36 191-199
• 35 Niimi M, Soto M, Wada Y, Takahra J, Kawanishi K. Effect of central and continuous intravenous infusion of IL-1 beta on brain cfos expression in the rat: involvement of prostaglandins.  NeuroImmunoModulation. 1996;  3 87-92
• 36 Parnet P, Kelley K W, Bluthe R M, Dantzer R. Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior.  J Neuroimmunol. 2002;  125 5-14
• 37 Pellow S, Chopin P, File S E, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.  J Neurosci Methods. 1985;  14 149-167
• 38 Plata-Salaman C R, Oomura Y, Kai Y. Tumour necrosis factor and interleukin-1 beta suppression of food intake by direct action on the central nervous system.  Brain Res. 1988;  448 106-114
• 39 Plunkett J A, Yu C G, Easton J M, Bethea J R, Yezierski R P. Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat.  Exp Neurol. 2001;  168 144-154
• 40 Popov N, Pohle W, Rosler V, Matthies H. Regional distribution of gamma-aminobutyric acid, glutamic acid, aspartic acid, dopamine, noradrenaline and serotonin in rat brain.  Acta Biol Med Ger. 1967;  18 695-702
• 41 Rothermundt M, Arolt V, Fenker J, Gutbrodt H, Peters M, Kirchner H. Different immune patterns in melancholic and non-melancholic major depression.  Eur Arch Psychiat Clin Neurosci. 2001;  251 90-97
• 42 Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. IL-1 stimulates the secretion of hypothalamic CRF.  Science. 1987;  238 522-524
• 43 Schlatter J, Ortuno F, Cervera-Enguix S. Monocytic parameters in patients with dysthymia versus major depression.  J Affect Disord. 2004;  78 243-724
• 44 Schwarz M J, Chiang S, Muller N, Ackenheil M. T-helper-1 and T-helper-2 responses in psychiatric disorders.  Brain Behav Immun. 2001;  15 340-370
• 45 Seyfried C A, Adam G, Greve T. An automated direct-injection HPLC-method for the electrochemical/fluorimetric quantitation of monoamines and related compounds optimized for the screening of large numbers of animals.  Biomed Chromatogr. 1986;  1 78-88
• 46 Shimizu N, Hori T, Nakane H. An IL-1 beta induced noradrenaline release in the spleen is mediated by brain CRF: an in vivo microdialysis study in conscious rats.  Brain Behav Immun. 1994;  7 14-23
• 47 Shintani F, Kanba S, Nakaki T, Nibuya M, Kinoshita N, Suzuki E. Interleukin-1beta augments the release of norepinephrine, dopamine and serotonin in rat anterior hypothalamus.  Neuroscience. 1993;  13 3574-3581
• 48 Smith R S. The macrophage theory of depression.  Med Hypotheses. 1991;  35 298-306
• 49 Song C, Han C, Halbreich U, Leonard B E, Meng F Q, Lou H C, Shen Y C. Effects of electronic acupuncture and fluoxetine treatments on plasma concentrations of pro- and anti-inflammatory cytokines in normal controls and depressed patients. Official Publication of the American College of Neuropsychopharmacology 2002: Abstract p 93
• 50 Song C, Leonard B E. The olfactory bulbectomised rat as a model of depression.  Neurosci Biobehav Rev. 2005;  29 627-647
• 51 Song C, Leonard B E. Changes in Behaviour, Neurochemistry, Endocrine, and Immune Functions Caused by Different Routes, Doses, and Durations of IL-1 Administration in the Rat.  Brain Behav Immun. 2001;  15 185
• 52 Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G. The Inflammatory Response System and the Tryptophan Availability to the Brain of Patients with Major Depression and Sleep Disorders.  J Affect Disord. 1998;  49 211-219
• 53 Song C, Li X, Leonard B E, Horrobin D F. Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats.  J Lipid Res. 2004;  44 1984-1991
• 54 Song C, Merali Z, Anisman H. Variation of nucleus accumbens dopamine and serotonin following systemic IL-1,IL-2 or IL-6 treatment.  Neuroscience. 1999;  88 823-836
• 55 Song C, Phillips A G, Leonard B E, Horrobin D F. Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1beta in rats.  Mol Psychiatry. 2004;  9 630-638
• 56 Spadaro F, Dunn A J. Intracerebrovascular administration of interleukin-1 to mice alters investigation of stimuli in a novel environment.  Brain Behav Immun. 1990;  4 308-322
• 57 Stanton P K, Sarvey J M. Depletion of norepinephrine, but not serotonin, reduces long-term potentiation in the dentate gyrus of rat hippocampal slices.  J Neurosci. 1985;  5 2169-2176
• 58 Strausbaugh H, Irwin M. Central corticotropin-releasing hormone reduces cellular immunity.  Brain Behav Immun. 1992;  6 11-17
• 59 van Dam A M, Brouns M, Louisse S, Berkenbosch F. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness?.  Brain Res. 1992;  588 291-296
• 60 Vitkovic L, Konsman J P, Bockaert J, Dantzer R, Hamburger V, Jacque C. Cytokine signals propagate through the brain.  Mol Psychiat. 2000;  5 604-615
• 61 Watkins L R, Maier S F, Goehler L E. Cytokine to brain communication: a review.  Life Sci. 1995;  11 1011-1026
• 62 Watt J A, Hobbs N K. Interleukin-1beta immunoreactivity in identified neurons of the rat magnocellular neurosecretory system: evidence for activity-dependent release.  J Neurosci Res. 2000;  60 478-489
• 63 Wichers M C, Koek G H, Robaeys G, Verkerk R, Scharpe S, Maes M. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.  Mol Psychiatry.. 2005;  10 538-544
• 64 Yirmiya R, Avitsur R, Donchin O, Cohen E. IL-1 inhibits sexual behaviour in female but not male rats.  Brain Behav Immun. 1995;  9 220-233